MicroRNA stability in postmortem FFPE tissues: Quantitative analysis using autoptic samples from acute myocardial infarction patients

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Kakimoto, Yu ^a   Kamiguchi, Hiroshi ^b   Ochiai, Eriko ^a   Satoh, Fumiko ^a   Osawa, Motoki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; MICRORNA; MICRORNA 1; MICRORNA 191; MICRORNA 208B; MICRORNA 26B; MICRORNA 499A; PARAFFIN; UNCLASSIFIED DRUG; MIRN1 MICRORNA, HUMAN; MIRN208 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN; SMALL NUCLEAR RNA; U6 SMALL NUCLEAR RNA;

ACUTE HEART INFARCTION; ADULT; ARTICLE; AUTOPSY; CONTROLLED STUDY; ELECTROPHORESIS; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; SUDDEN CARDIAC DEATH; AGED; CHEMISTRY; FEMALE; GENETICS; HEART INFARCTION; MIDDLE AGED; PATHOLOGY; POSTMORTEM CHANGE; TIME FACTOR; TISSUE FIXATION;

ADULT; AGED; AUTOPSY; FEMALE; FORMALDEHYDE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; PARAFFIN EMBEDDING; POSTMORTEM CHANGES; REAL-TIME POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, SMALL NUCLEAR; TIME FACTORS; TISSUE FIXATION;

EID: 84934924438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129338     Document Type: Article

References (45)

1. th Ed. Philadelphia, PA: Saunders; 2010. pp. 545-558.
2. Kakimoto Y, Tsuruyama T, Miyao M, Abiru H, Sumiyoshi S, Kotani H, et al. The effectiveness and limitations of triphenyltetrazolium chloride to detect acute myocardial infarction at forensic autopsy. Am J Forensic Med Pathol. 2013; 34: 242-247. doi: 10.1097/PAF.0b013e31828879cd PMID: 23949140
3. Kakimoto Y, Ito S, Abiru H, Kotani H, Ozeki M, Tamaki K. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients. J Am Heart Assoc. 2013; 2: e000565. doi: 10.1161/JAHA.113.000565 PMID: 24342996
4. Deddens JC, Colijn JM, Oerlemans MI, Pasterkamp G, Chamuleau SA, Doevendans PA, et al. Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J Cardiovasc Transl Res. 2013; 6: 884-898. doi: 10.1007/s12265-013-9493-9 PMID: 23897095
5. Ambros V. The functions of animal microRNAs. Nature. 2004; 431: 350-355. PMID: 15372042
6. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11: 597-610. doi: 10.1038/nrg2843 PMID: 20661255
7. Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L. Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep. 2014; 4: 5150. doi: 10.1038/srep05150 PMID: 24889152
8. Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012; 13: 239-250. doi: 10.1038/nrm3313 PMID: 22436747
9. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012; 110: 483-495. doi: 10.1161/CIRCRESAHA.111.247452 PMID: 22302755
10. Di Leva G, Croce CM. MiRNA profiling of cancer. Curr Opin Genet Dev. 2013; 23: 3-11. doi: 10.1016/j.gde.2013.01.004 PMID: 23465882
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513-10518. doi: 10.1073/pnas.0804549105 PMID: 18663219
12. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18: 997-1006. doi: 10. 1038/cr.2008.282 PMID: 18766170
13. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002; 161: 1961-1971. PMID: 12466110
14. Turashvili G, Yang W, McKinney S, Kalloger S, Gale N, Ng Y, et al. Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques. Exp Mol Pathol. 2012; 92: 33-43. doi: 10.1016/j.yexmp.2011.09.013 PMID: 21963600
15. Macabeo-Ong M, Ginzinger DG, Dekker N, McMillan A, Regezi JA, Wong DT, et al. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Mod Pathol. 2002; 15: 979-987. PMID: 12218216
16. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA. 2007; 13: 1668-1674. PMID: 17698639
17. Meng W, McElroy JP, Volinia S, Palatini J, Warner S, Ayers LW, et al. Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. PLoS One. 2013; 8: e64393. doi: 10.1371/journal.pone.0064393 PMID: 23696889
18. Muciaccia B, Vico C, Aromatario M, Fazi F, Cecchi R. Molecular analysis of different classes of RNA molecules from formalin-fixed paraffin-embedded autoptic tissues: a pilot study. Int J Legal Med. 2015; 129: 11-21. doi: 10.1007/s00414-014-1066-1 PMID: 25135750
19. Wong L, Lee K, Russell I, Chen C. Endogenous controls for real-time quantitation of miRNA using Taq-Man microRNA assays. Appied Biosystems Application Note. 2007. Publication 127AP11-01. Available: www.appliedbiosystems.com.
20. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008; 14: 844-852. doi: 10.1261/rna.939908 PMID: 18375788
21. Bronze-da-Rocha E. MicroRNAs expression profiles in cardiovascular diseases. Biomed Res Int. 2014; 2014: 985408. doi: 10.1155/2014/985408 PMID: 25013816
22. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55: 611-622. doi: 10.1373/clinchem.2008.112797 PMID: 19246619
23. Applied Biosystems. Guide to performing relative quantitation of gene expression using real-time quantitative PCR. Applied Biosystems, Foster City, CA. 2008.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408. PMID: 11846609
25. Peiro-Chova L, Pena-Chilet M, Lopez-Guerrero JA, Garcia-Gimenez JL, Alonso-Yuste E, Burgues O, et al. High stability of microRNAs in tissue samples of compromised quality. Virchows Arch. 2013; 463: 765-774. doi: 10.1007/s00428-013-1485-2 PMID: 24197449
26. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res. 2005; 33: e56. PMID: 15800207
27. Micke P, Ohshima M, Tahmasebpoor S, Ren ZP, Ostman A, Ponten F, et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest. 2006; 86: 202-211. PMID: 16402036
28. Haile S, Estevez AM, Clayton C. A role for the exosome in the in vivo degradation of unstable mRNAs. RNA. 2003; 9: 1491-1501. PMID: 14624005
29. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006; 7: 3. PMID: 16448564
30. Slagter-Jager JG, Nicolette CA, Tcherepanova IY. Evaluation of a microfluidics-based platform and slab electrophoresis for determination of size, integrity and quantification of in vitro transcribed RNA used as a component in therapeutic drug manufacturing. J Pharm Biomed Anal. 2012; 70: 657-663. doi: 10.1016/j.jpba.2012.04.031 PMID: 22703839
31. Moret I, Sanchez-Izquierdo D, Iborra M, Tortosa L, Navarro-Puche A, Nos P, et al. Assessing an improved protocol for plasma microRNA extraction. PLoS One. 2013; 8: e82753. doi: 10.1371/journal.pone.0082753 PMID: 24376572
32. Becker C, Hammerle-Fickinger A, Riedmaier I, Pfaffl MW. mRNA and microRNA quality control for RT-qPCR analysis. Methods. 2010; 50: 237-243. doi: 10.1016/j.ymeth.2010.01.010 PMID: 20079844
33. Zhang H, Zhang P, Ma KJ, Lv YH, Li WC, Luo CL, et al. The selection of endogenous genes in human postmortem tissues. Sci Justice. 2013; 53: 115-120. doi: 10.1016/j.scijus.2012.11.005 PMID: 23601718
34. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010; 3: 499-506. doi: 10.1161/CIRCGENETICS.110.957415 PMID: 20921333
35. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G, et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol. 2013; 167: 531-536. doi: 10.1016/j.ijcard.2012.01.075 PMID: 22330002
36. Xiao J, Shen B, Li J, Lv D, Zhao Y, Wang F, et al. Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction. Int J Clin Exp Med. 2014; 7: 136-141. PMID: 24482699
37. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010; 391: 73-77. doi: 10.1016/j.bbrc.2009.11.005 PMID: 19896465
38. Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci. 2012; 8: 811-818. doi: 10.7150/ijbs.4439 PMID: 22719221
39. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet. 2011; 4: 446-454. doi: 10.1161/CIRCGENETICS.110.958975 PMID: 21642241
40. Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res. 2009; 105: 585-594. doi: 10.1161/CIRCRESAHA.109.200451 PMID: 19679836
41. Lv P, Zhou M, He J, Meng W, Ma X, Dong S, et al. Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction. Int J Mol Sci. 2014; 15: 5774-5788. doi: 10.3390/ijms15045774 PMID: 24714087
42. Bostjancic E, Zidar N, Stajer D, Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology. 2010; 115: 163-169. doi: 10.1159/000268088 PMID: 20029200
43. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest. 2009; 119: 2772-2786. doi: 10.1172/JCI36154 PMID: 19726871
44. Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail. 2010; 16: 404-410. doi: 10.1016/j.cardfail.2010.01.002 PMID: 20447577
45. Plattner T, Yen K, Zollinger U. The value of subendocardial haemorrhages as an indicator of exsanguination and brain injury - A retorospective forensic autopsy study. J Forensic Leg Med. 2008; 15: 325-328. doi: 10.1016/j.jflm.2007.12.019 PMID: 18511009